Difficulty: Medium
Average Score: 82%
Practice
The antenatal administration of magnesium sulfate before preterm delivery has been suggested to
Correct answer
B
Rationale
The correct answer is B) Decrease the risk of cerebral palsy in surviving infants.
Magnesium sulfate has been shown to have neuroprotective effects in preterm infants. When administered antenatally to mothers at risk of preterm delivery, it crosses the placenta and exerts its protective effects on the developing fetal brain. This can lead to a decreased risk of cerebral palsy in surviving infants.
Option A) Reduce rates of necrotizing enterocolitis is incorrect because magnesium sulfate administration is not associated with reducing the rates of this gastrointestinal condition in preterm infants.
Option C) Improve overall survival is incorrect because while magnesium sulfate may have beneficial effects on specific outcomes like cerebral palsy, its use is not directly linked to improving overall survival rates of preterm infants.
Option D) Decrease respiratory distress syndrome in premature infants is incorrect because although magnesium sulfate may have some effects on lung development, its primary benefit lies in neuroprotection rather than reducing respiratory distress syndrome.
In an educational context, understanding the rationale behind the use of magnesium sulfate in preterm labor is crucial for pediatric nurses caring for premature infants. This knowledge helps nurses provide informed care, advocate for evidence-based practices, and communicate effectively with other healthcare team members and families about the potential benefits and risks of this intervention.
Magnesium sulfate has been shown to have neuroprotective effects in preterm infants. When administered antenatally to mothers at risk of preterm delivery, it crosses the placenta and exerts its protective effects on the developing fetal brain. This can lead to a decreased risk of cerebral palsy in surviving infants.
Option A) Reduce rates of necrotizing enterocolitis is incorrect because magnesium sulfate administration is not associated with reducing the rates of this gastrointestinal condition in preterm infants.
Option C) Improve overall survival is incorrect because while magnesium sulfate may have beneficial effects on specific outcomes like cerebral palsy, its use is not directly linked to improving overall survival rates of preterm infants.
Option D) Decrease respiratory distress syndrome in premature infants is incorrect because although magnesium sulfate may have some effects on lung development, its primary benefit lies in neuroprotection rather than reducing respiratory distress syndrome.
In an educational context, understanding the rationale behind the use of magnesium sulfate in preterm labor is crucial for pediatric nurses caring for premature infants. This knowledge helps nurses provide informed care, advocate for evidence-based practices, and communicate effectively with other healthcare team members and families about the potential benefits and risks of this intervention.